Core Insights - Nuwellis, Inc. announced participation in a Virtual Investor segment discussing a significant NIH grant awarded to its development partner, Koronis Biomedical Technologies Corporation [2][3] - The NIH grant, approximately $3 million, aims to accelerate the development of Nuwellis' pediatric continuous renal replacement therapy device, Vivian™, for patients under 20 kilograms [3] Company Overview - Nuwellis, Inc. is a medical technology company focused on fluid management solutions for critically ill patients, with a commitment to innovation and collaboration [5] - The company is commercializing the Aquadex SmartFlow system for ultrafiltration therapy and is headquartered in Minneapolis, with a subsidiary in Ireland [5]